Gabriela Schäfer completed her Bachelor of Science in Biomedical Chemistry at the Johannes Gutenberg-University Mainz (Germany), followed by completing her Master studies in Biomedical Chemistry at the Johannes Gutenberg-University Mainz (Germany). Her main research during her studies was focused on the development of nanoparticle-based anti-tuberculosis therapies. In the PET-AlphaSy Network, she will be working on the development of antibody-functionalized PeptoBrushes for alpha-synuclein in Parkinson´s disease.
Institut für Organische Chemie
Johannes Gutenberg-Universität Mainz
Polypept(o)ides in pretargeted imaging: From probes to clearing agents